Empa 10MG T-005

Download as doc, pdf, or txt
Download as doc, pdf, or txt
You are on page 1of 48

BRIELL Pharmaceuticals

BATCH MANUFACTURING RECORD

Tablet Section
Product Name: EMPA 10MG Tablet
1 Batch Number: T-005

3 Batch Size: 2000Tabs . .

4 Manufacturing Date: 05-2022 .

5 Expiry Date: 04-2024 .

6 Shelf Life: 24Months .

7 Pack Size: 2*7s .

8 Registration Number: -------- .

9 BMR Issued Date:. 09-05-2022

10 BMR Submission Date: 10-05-2022

Instruction:
1. Fill the BMR accurately, avoid cutting & overwriting. In case of any mistake/ error, cut that word or line with a single stroke and do initials there.
2. Check the materials for their identity (by name, Batch no and Release status) and quantity.
3. Ensure line clearance prior to start of each process.
4. Ensure compliance of environmental conditions (Temperature, Relative Humidity and Differential Pressure) during all manufacturing operations whenever necessary.
5. Use mask, Gloves, cap and uniform during process. (As per requirement)
6. Do not touch any moving parts of the machine while in operation. Use all the electrical board/panel carefully and keep away from any spillage.
7. Strictly follow all the steps of standard operating procedures.
8. Make sure all safety guards and side panels are in position before and after starting machine.
9. In case of any deviation, immediately inform and get permission from senior corrective and preventive action and document all the deviations.
10. Product Status of all the steps of manufacturing and packing operations must be displayed.
Note: All the equipment and utensils must be properly cleaned and properly labeled.

Reviewed By: ____________________ Approved By:________________


Section Incharge QA Officer

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 1 of 48
BRIELL PHARMACEUTICALS Production Dept.

Product Code: Doc no: R&D/BMR/001


PRODUCT NAME: EMPA 10MG TABLET Revision no: 00
Reg NO: ------- BATCH NO:T-005 Batch Size: 2000Tab Mfg.: 05-2022 Exp.: 04-2024 Revision date:01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Director Operations

BMR COMPLIANCE CHECKLIST


Availability of Availability of
Documents and Page Sr. Documents and Page
Sr. # TABLE OF CONTENTS Compliance TABLE OF CONTENTS Compliance
No. # No.
Yes  √ No  x Yes  √ No x
1. Cover page & General Instructions 01 24 Equipment Cleaning Status 27
2. BMR Compliance Checklist 02 25 Standard Manufacturing Procedure for Coating 28
3. Master Formulation 03 26 Weight Record of Coated Tablets & Yield Calculation 29
4. Calculation of API 04 27 Quality Control Testing Report After Coating 30
5. Manufacturing Order 05-06 28 Packing Order 31-32
6. Line Clearance Checklist for Dispensing 07 29 Line Clearance Checklist for Blistering 33
7. Verification of Dispensed Raw Materials 08 30 Equipment Cleaning Status & Embossing Information 34
List of Equipment Used During Manufacturing & Packing 35
8. 09 31 Line Clearance Checklist for Blistering P/S
Process
9. Line Clearance Checklist for Granulation 10 32 Equipment Cleaning Status & Embossing Information P/S 36
10. Standard Manufacturing Procedure for Granulation 11-13 33 In process Control sheet for Blistering 37
11. Quality Control Testing Report (Moisture contents) 14 34 Team Layout Sheet at Blistering Stage 38
12. Granulation Procedure (Final Mixing) 15 35 Line Clearance Checklist for Printing Machine & Area 39
13. Weight Record of Grains & Yield Calculation 16 36 Over Printing Information 40-41
14. Quality Control Testing Report at Final Mixing Stage 17 37 In process Control SHEET for Printing 42
15. Line Clearance Checklist for Compression 18 38 Team Layout Sheet at Printing Stage 43
16. Equipment Cleaning Status & Product Specification 19 39 Line Clearance Checklist for Packing 44
17. Compression Start Up Analysis Sheet 20 40 Team Layout Sheet at Packing Stage 45
18. Weight Control Sheet for Compression 21 41 In process Control SHEET for Packing 46
19. In process Weight Monitoring Sheet 22 42 Certificate of Analysis 47
20. In process Control Sheet for Compression 23 43 Finished Goods Transfer Note 48-49
21. Weight Record of Compressed Tablet & Yield Calculation 24 44 Packing Material Reconciliation 50
22. Quality Control Testing Report After Compression 25 45 Batch Reconciliation 51
23. Line Clearance Checklist for Coating 26 46 Destruction Note 52
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
All the above documentsSTAMP
are checked and found satisfactory. Checked By: _______________ Reviewed By: ____________
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Section In charge QA Officer
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 2 of 48
BRIELL PHARMACEUTICALS Production Dept.

Product Code: Doc no: R&D/BMR/001


PRODUCT NAME: EMPA 10MG TABLET Revision no: 00
Reg NO: ------- BATCH NO:T-005 Batch Size: 2000Tab Mfg.: 05-2022 Exp.: 04-2024 Revision date:01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Director Operations

MASTER FORMULATION FOR RAW MATERIAL

Each Tablet Standard Batch


Sr. # Raw Materials
Contains (mg) Size (2000Tablets.)
1. Empagliflozin 10.00mg 20.00gm
2. Lactose monohydrate 95.238mg 190.476gm
3. Starch 50.855mg 101.71gm
4. PVP K 30 4.30mg 8.60gm
5. Primojel 2.00mg 4.00gm
6. Purified Water 0.05ml 100ml
7. Magnesium stearate 5.11mg 10.22gm
8. Avicel-102 41.10mg 82.20gm
9. Aerosil-200 1.50mg 3.00gm
10. Coat Dry White 11.00mg 22.00gm
11. IPA 0.176ml 352ml
12. Titanium Dioxide 2.20mg 4.40gm
13. PEG 6000 2.20mg 4.40gm
14. RO Water 0.044ml 88.00ml

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 3 of 48
BRIELL PHARMACEUTICALS Production Dept.

Product Code: Doc no: R&D/BMR/001


PRODUCT NAME: EMPA 10MG TABLET Revision no: 00
Reg NO: ------- BATCH NO:T-005 Batch Size: 2000Tab Mfg.: 05-2022 Exp.: 04-2024 Revision date:01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Director Operations

CALCULATION OF ACTIVE PHARMACEUTICAL INGREDIENT (API)

API Empagliflozin................10 mg
Each film coated tablet contains:
Label Claim Empagliflozin.......... 10mg
(Innovator’s Specifications)

Assay of API (Potency): 99.60% (as such)

Overage of API: _______________________

Label Claim: 10mg per Tablet

Weight of API per tablet( mg) = 100_ x Label Claim = 10.04mg/Tablet


Assay of API (potency)

Weight of API per batch(kg) = mg/Tablet x batch size = 20.08 g/batch size
1000g

Total Weight of API (g): __________20.08g________________________

Remarks (if any): __________________________________________


CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Calculated By:_______________Checked By: ____________Verified By: ___________ Approved By: ____________ Section Incharge
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
Production Manager QC Manager QA Manager
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 4 of 48
BRIELL PHARMACEUTICALS Production Dept.

Product Code: Doc no: R&D/BMR/001


PRODUCT NAME: EMPA 10MG TABLET Revision no: 00
Reg NO: ------- BATCH NO:T-005 Batch Size: 2000Tab Mfg.: 05-2022 Exp.: 04-2024 Revision date:01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Director Operations

MANUFACTURING ORDER For Production Use


Date: _____________
Product Name: EMPA 10MG Tablet Batch No: T-005
Manufacturing Date: 05-2022 Expiry Date: 04-2024
Batch Size (Kg): 420.246gm Batch Quantity: 2000Tab
Registration No: ----- Shelf Life : 24months
Section: General Tablet Section
Checked Received By
Qty. Additional Qty Dispensed Verified
QC. No Raw Materials Qty. Issued Return Actual Used By Disp.
By QA Officer
Production
Reqd. Issued By Pharmacist Pharmacist

Empagliflozin
20.00 gm 20.04 gm
Lactose monohydrate 190.47 gm 190.47 gm
Starch 101.71gm 101.71gm
PVP K 30 8.60 gm 8.6 gm
Primojel 4.00 gm 4.00 gm
Magnesium stearate 10.22 gm 10.22 gm
Avicel-102 82.20 gm 82.20 gm
Aerosil-200 3.00 gm 3.00 gm
Coating Material Dispensing
Checked Received By
Qty. Additional Dispensed Verified
QC. No Raw Materials Qty. Issued Return Actual Used By Disp.
By QA Officer
Production
Reqd. Qty Issued By Pharmacist Pharmacist

Coat Dry White 21.00gm 21.00gm


IPA 352.0ml 352.0ml
Titanium Dioxide 4.40gm 4.40gm
PEG 6000 4.40gm 4.40gm
RO Water 88.00ml 88.00ml
MANUFACTURING ORDER For Warehouse Use
Date: _____________ CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Product Name: Calculated
STAMP By:_________________
CONTROLLED COPY: EMPA NO10MG Checked
COPYING
By: ____________________
TabletWITHOUT MANAGER Q.ABatch
Verified By: ________________ Approved by:
No:
PERMISSION
_________
T-005
Manufacturing Date: Section 05-2022
Incharge Production Manager Expiry Date: QC Manager QA manager
04-2024
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
Batch Size (Kg): 420.246gm Batch Quantity: 2000Tab
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 5 of 48
BRIELL PHARMACEUTICALS Production Dept.

Product Code: Doc no: R&D/BMR/001


PRODUCT NAME: EMPA 10MG TABLET Revision no: 00
Reg NO: ------- BATCH NO:T-005 Batch Size: 2000Tab Mfg.: 05-2022 Exp.: 04-2024 Revision date:01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Director Operations

Registration No: --------- Shelf Life : 24 Months


Section: General Tablet Section
Checked Received By
Qty. Additional Qty Dispensed Verified
QC. No Raw Materials Qty. Issued Return Actual Used By Disp.
By QA Officer
Production
Reqd. Issued By Pharmacist Pharmacist

Empagliflozin
20.00 gm 20.04 gm
Lactose monohydrate 190.47 gm 190.47 gm
Starch 101.71gm 101.71gm
PVP K 30 8.60 gm 8.60 gm
Primojel 4.00 gm 4.00 gm
Magnesium stearate 10.22 gm 10.22 gm
Avicel-102 82.20 gm 82.20 gm
Aerosil-200 3.00 gm 3.00 gm
Coating Material Dispensing
Checked Received By
Qty. Additional Dispensed Verified
QC. No Raw Materials Qty. Issued Return Actual Used By Disp.
By QA Officer
Production
Reqd. Qty Issued By Pharmacist Pharmacist

Coat Dry White 21.00gm 21.00gm


IPA 352.0ml 352.0ml
Titanium Dioxide 4.40gm 4.40gm
PEG 6000 4.40gm 4.40gm
RO Water 88.00ml 88.00ml
LINE CLEARANCE CHECKLIST FOR DISPENSING
DISP. OFFICER QA OFFICER
Sr. # Calculated By:_________________ Checked By: ____________________
CLEARANCE PARAMETERS Verified By: ________________ Approved by: _________
Yes No Yes No
Section Incharge Production Manager QC Manager QA manager
01 Is area properly cleaned and labeled?    
02 Are there any traces of previous Product _________________Batch # ____________in    
a- Area, Equipment, Tools, Containers, Pallets    
b- CONTROLLED
Dispensing Hood COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION    
c- STAMP
Platform Weighing balance
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION    
d- TopRED STAMPWeighing balance
Loading    
STAMP INDICATES ORIGIONAL DOCUMENT
STARTUP PARAMETERS
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 6 of 48
BRIELL PHARMACEUTICALS Production Dept.

Product Code: Doc no: R&D/BMR/001


PRODUCT NAME: EMPA 10MG TABLET Revision no: 00
Reg NO: ------- BATCH NO:T-005 Batch Size: 2000Tab Mfg.: 05-2022 Exp.: 04-2024 Revision date:01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Director Operations

03 Are equipment & containers properly cleaned & labeled with Equipment / Product Identification Label?    
04 Are Personnel in the dispensing room wearing specified cleaned uniform, gloves and mask?    
Is Temperature and relative humidity in accordance with the requirements and recorded?
05    
Temperature:_______(°C) & Humidity:_________(%)
06 Are log books maintained properly?    
07 Are weighing balances in calibrated status?    
08 Is Differential Pressure in accordance with the requirements and recorded?    
09 Is dispensing hood properly in working condition?    
10 Are all dispensing tools used in dispensing, properly cleaned and wrapped in polythene bag having cleaned status?    
11 Are Raw materials to be dispensed having proper identification label and QC release?    
12 Is approved manufacturing order pertaining to the batch to be dispensed, available and as per requiBlack batch size?    
13 Are Dispensing tags available as per manufacturing order?    
All the above parameters are checked and found satisfactory
PRODUCTION PHARMACIST _______________ DATE & TIME:_______________ LINE CLEARANCE AWARDED: YES □ NO □
QA OFFICER ___________________ DATE & TIME:________________ REMARKS: _______________________

LINE CLEARANCE FOR MORE THAN ONE TIME AFTER RECHECKING OF ABOVE PARAMETERS EACH TIME
DATE TIME LINE CLEARANCE STATUS CHECKED BY RECHECKED BY IPQC

VERIFICATION OF DISPENSED RAW MATERIALS


All the Dispensed Raw Material Identification Slips Are Attached Here

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 7 of 48
BRIELL PHARMACEUTICALS Production Dept.

Product Code: Doc no: R&D/BMR/001


PRODUCT NAME: EMPA 10MG TABLET Revision no: 00
Reg NO: ------- BATCH NO:T-005 Batch Size: 2000Tab Mfg.: 05-2022 Exp.: 04-2024 Revision date:01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Director Operations

1. All belongings of the previous product/ Material are


All the above dispensed materials are checked and received as per Manufacturing order.

Checked by: ___________________ Verified by: ___________________


Production Pharmacist QA Officer

LIST OF EQUIPMENT USED DURING MANUFACTURING


AND PACKING PROCESS and CLEANING STATUS
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 8 of 48
BRIELL PHARMACEUTICALS Production Dept.

Product Code: Doc no: R&D/BMR/001


PRODUCT NAME: EMPA 10MG TABLET Revision no: 00
Reg NO: ------- BATCH NO:T-005 Batch Size: 2000Tab Mfg.: 05-2022 Exp.: 04-2024 Revision date:01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Director Operations

Sr. Equipment ID
Description Cleaning Status
#
Sigma Mixer BM/R&D/001
1
Rotary wet granulator BM/R&D/002
2
Powder tray dryer BM/R&D/003
3
Oscillating Dry granulator BM/R&D/004
4
5 Double cone mixer BM/R&D/005
6 Rotary tablet press ZP-17 BM/R&D/006
7 Dust collector -----
8 Double jacket coating mixer BM/R&D/007
9 Coating pan SS BM/R&D/008
10 ALU-ALU blister machine 4001
11 LASER Jet printer 4003
12 Conveyer belt 4002

All the above mentioned equipment are checked and found in proper working condition.

Checked By: ___________________ Verified By: ______________


Production Pharmacist QA Officer

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 9 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

LINE CLEARANCE CHECKLIST FOR GRANULATION


PRD OFFICER QA OFFICER
Sr.# CLEARANCE PARAMETERS
Yes No Yes No
01 Is area properly cleaned and labeled?    
02 Are there any traces of previous Product ______________Batch #___________in    
a- Area, Containers, Equipment & Measuring Tools    
b- Mechanical Sifter    
c- Mixer Granulator    
d- Platform Weighing Balance    
START UP OPERATION
03 Are equipments & containers properly labeled with Equipment / Product Identification Label?    
04 Are personnel in the granulation area wearing specified clean uniform, gloves and masks?    
05 Are log books maintained properly?    
06 Is weighing balance calibrated?    
Is Temperature and relative humidity in accordance with the requirements and recorded?
07    
Temperature:_______(°C) & Humidity:_________(%)
08 Is Differential Pressure in accordance with the requirements and recorded?    
09 Are dispensed raw materials pertaining to respective batch available?    
10 Is documentation of previous stages completed?    
All the above parameters are checked and found satisfactory.

PRODUCTION PHARMACIST _______________ DATE & TIME:_______________ Line Clearance awarded: YES □ NO □
QA OFFICER ___________________ DATE & TIME:________________ REMARKS: _______________________

LINE clearance for more than one time after rechecking of above parameters each time
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Date Time Line clearance status Checked by Rechecked by IPQC
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 10 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

STANDARD MANUFACTURING PROCEDURE FOR GRANULATION


Performed Checked By Verified
Step
GRANULATION PROCEDURE By Production By QA
#
Operator Pharmacist Officer
1 DRY MIXING:
Sr.# Ingredients Actual Wt. (Kg)
1 Lactose Monohydrate
2. Starch
Sieve materials through mesh # 12. Transfer the above sieved material to mixer.
Mix the above material for 15 to 20 minutes.
Mixing Started at: ____________ Mixing Completed at: __________
Total Mixing Time: ___________ Date:__________
2 BINDER SOLUTION PREPARATION:

Sr.# Ingredients Actual Wt. (Kg)


1. PVP K 30
2. Purified Water
Dissolve starch in small portion of purified water at room tempaerature. Than add this mix in remaining quantity of warm
purified water in which PVP K 30 is already dissolved. Heat till binder solution is prepared. Allow the solution to cool at
room temperature before application.

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 11 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Performed Checked By Verified


Step GRANULATION PROCEDURE By Production By QA
# Operator Pharmacist Officer
3 WET MIXING:
Now add binder solution into mixer & wet the previously sieved material present in mixer. Run the mixer for 10 minutes.
Wet mixing started at:________ Wet mixing completed at:________
Total wet mixing Time: ________ Date:__________
WET GRANULATION:
Pass the wet material through rotary granulator to obtain grains which are then spread into trays for drying.
4
Wet granulation started at:________ Wet granulation completed at:________
Total wet granulation Time: ________ Date:__________
DRYING:
5 After wet granulation transfer the granulated material to Tray Dryer and dry the material at 70°C.
Drying Started at: _________ Drying Completed at: _________
Total Drying Time: ________ Date:__________
Send request to QA for sampling after complete drying of grains for the checking of Moisture contents which should be
NMT 5 %.
Sampled Quantity: ______________ gm

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 12 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Performed Checked By Verified


Step GRANULATION PROCEDURE By Production By QA
# Operator Pharmacist Officer

6 SIEVING :

After drying, fix _____ # mesh on oscillating granulator and pass the dried material through it. Collect the grains in
polythene lined labeled containers.
Sieving Started at: _________ Sieving Completed at: _________
Total Sieving Time: ________ Date:__________

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
QUALITY CONTROL TESTING REPORT (MOISTURE CONTENT)
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 13 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
General Tablet Section After Drying
Filled By Quality Assurance
Date: Time: Sampled By: Quantity: QA Officer (Sign)

Analysis Report (Filled By QC)


Sample Receiving Sample Receiving Sample Release Sample Release Time: QC Reference
Date: Time: Date: No.

Tests Specifications Results


Loss on Drying NMT 5.0 %

Remarks: _________________________________________________________________________

Performed By: ______________ Checked by: _________________ Approved by: ______________


QC Analyst Asst. QC Manager QC Manager

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 14 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Performed Checked By Verified


Step # GRANULATION PROCEDURE By Production By QA
Operator Pharmacist Officer
5 FINAL MIXING:
Sr.# Ingredients Actual Wt. (Kg)
1. Empagliflozin
2. Avicel-102
3. Primojel
Pass material 1&2 through mesh # 16 and transfer into double cone mixer for final mixing. Run the mixer for 25-30 minutes.
6 Mixing Started at: _________ Mixing Completed at: _________
Total Mixing Time: ________ Date:__________
LUBRICATION:
Sr.# Ingredients Actual Wt. (Kg)
1. Mg. Stearate
2. Aerosil-200
Pass Magnesium Stearate through mesh #30 and transfer into double cone mixer for mixing. Run the mixer for 2-5
minutes.
Mixing Started at: _________ Mixing Completed at: _________

Total Mixing Time: ________ Date:__________


Discharge the material from cone mixer through butterfly valve in the tarred containers equipped with clean
polythene bags. Send requestCOPY:
CONTROLLED to QANO
forCOPYING
samplingWITHOUT
after finalMANAGER
mixing. Q.A PERMISSION
STAMP
Sampled Quantity: ______________
CONTROLLED COPY: NOgmCOPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 15 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

WEIGHT RECORD OF GRAINS & YIELD CALCULATION


Date: ______________
Container Performed By Checked By Production Verified By QA
Gross Weight (Kg) Tare Weight (Kg) Net Weight (Kg)
Number Operator Pharmacist Officer
1
2
3

TOTAL NET WEIGHT _________________Kg.

Theoretical weight of Grains =___________ Kg


Actual weight of Grains =_______________ Kg
% Yield = __________________________ %
Wastage = ____________________________%

Note: Store the grains with proper Air tight Polythene bags in labeled containers in in-process Quarantine Area.

Performed by: ___________Checked by: ________________ Verified by: ____________


Operator Production Pharmacist QA Officer

Transfer Of Grains from In-process Quarantine Area to Compression Section:

Total Weight received: _______________ Date: _________________________


CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Recieved by: ______________________
STAMP Checked by: ___________________
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMPOperator Production Pharmacist
RED STAMP INDICATES ORIGIONAL DOCUMENT
QUALITY CONTROL TESTING REPORT AT FINAL MIXING STAGE
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 16 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
General Tablet Section Final mixing
Filled By Quality Assurance
Date: Time: Sampled By: Quantity: QA Officer (Sign)

Analysis Report (Filled By QC)


Sample Receiving Date: Sample Receiving Time: Sample Release Date: Sample Release Time: QC Reference No.

Tests Specifications Results


Physical Appearance White to Off White Color Granular Powder
Identification:
Loss on Drying NMT 5%
Assay: 90-110% as label claim of Empagliflozin

Proposed weight: Compression Range:

Remarks: _________________________________________________________________________

Performed By: ______________ Checked by: _________________ Approved by: ______________


QC Analyst Asst. QC Manager QC Manager

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 17 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

LINE CLEARANCE CHECKLIST FOR COMPRESSION


Sr.# PRD OFFICER QA OFFICER
CLEARANCE PARAMETERS Yes No Yes No
01 Is area properly cleaned and labeled?    
02 Are there any traces of previous Product _____________ Batch #_________ in    
a- Area, Containers, Machine Tools.    
b- Tablet Compression Machine    
c- Top Loading Weighing Balance    
START UP OPERATION
03 Are equipment & containers properly cleaned & labeled with Equipment / Product Identification Label?    
04 Are personnel in compression area wearing specified cleaned uniform, gloves and mask?    
05 QC release of the batch to be processed is present?    
06 Are log books maintained properly?    
07 Is balance in calibrated status?    
Is Temperature And relative humidity in accordance to the requirements and recorded?
08
Temperature:_______(°C) & Humidity:_________(%)
   
09 Is Differential Pressure in accordance to the requirements and recorded?    
10 Is documentation of previous stages completed?    
All the above parameters are checked and found satisfactory.
PRODUCTION PHARMACIST:_______________ DATE & TIME:_______________ Line Clearance awarded: YES □ NO □
QA OFFICER:_____________________ DATE & TIME:________________ REMARKS: ___________________________________

LINE clearance for more than one time after rechecking of above parameters each time
Date Time Line clearance status Checked by Rechecked by IPQC
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
PRODUCT SPECIFICATIONS (CORE TABLETS)
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 18 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Physical Appearance: White Colored One Side Engraved Cut line Round Tablet
Punch Shape: Round
Punch size: 8 mm
Average weight: 210mg / tablet
Weight variation Limit: ± 7.5 %
Range: 194.25-225.75mg
Diameter: 8±0.04mm
Thickness: 5±0.04mm
Hardness: NMT 10 kg
Disintegration time: NMT 15 mint
Friability: NMT 1 %

Punches, Dies and Tablets verification:

Dies & Punches should be checked for proper fitting. Tablets of first round checked by Production Pharmacist (all physical parameters except disintegration) and after
machine adjustment Production pharmacist will send intimation to concerned QA Officer to collect sample for physical analysis such as Appearance, Diameter, Thickness,
Hardness, Friability, Average Wt., Disintegration Time, and Wt. Variation of tablets.

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP COMPRESSION START UP ANALYSIS SHEET
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 19 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
General Tablet Section Compression
Filled By Quality Assurance
Date: Time: Sampled By Quantity QA Officer (Sign)

Average Weight: Range:


Sr. # Wt. / Tablet (mg) Sr. # Wt. / Tablet (mg) Sr. # Wt. / Tablet (mg) Sr. # Wt. / Tablet (mg)
1 6 11 16
2 7 12 17
3 8 13 18
4 9 14 19
5 10 15 20
Avg. Wt. / 20 Tablets :
Hardness:
Disintegration Time :
Friability :
Diameter:
Thickness:

Remarks ( if any ) :

QC Analyst _______________________ QC Manger __________________


CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
IN-PROCESS
RED STAMP INDICATES ORIGIONAL DOCUMENT WEIGHT MONITORING SHEET
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 20 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Date: ___________ Start Time: ____________ Close Time: ___________


Proposed weight: Lower Limit : Upper Limit:
Date
Sr.#
Time
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Avg. Wt.

Production Officer ________________ QA Officer : ________________


Note: 1) QA officer will use Black ball point.COPY:
CONTROLLED 2) InNO
process entries are
COPYING taken every
WITHOUT 45 minutesQ.A
MANAGER by QA and production alternatively.
PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
INPROCESS CONTROLSHEET FOR COMPRESSION
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 21 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

S. No Time Disintegration Friability Hardness Length/ Thickness Color of Checked By


Time Diameter Tablet

Checked by: __________________ Verified by: ____________


Production Officer QA Officer

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP WEIGHT RECORD OF COMPRESSED TABLET
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
& YIELD CALCULATION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 22 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Date: ______________
Container Tare Weight Net Weight Checked By Production Verified By QA
Gross Weight (Kg) Performed By Operator
Number (Kg) (Kg) Pharmacist Officer
1

4
TOTAL NET WEIGHT _________________Kg.

Theoretical weight of grains:_____________ Kg Actual weight of compressed tablets:___________ Kg

% Yield = _________________ % % Wastage = ________________%


Note: Store the core tablets in proper Air tight Polythene bags, in labeled containers, in in-process Quarantine Area

Performed by: ____________ Checked by: __________________ Verified by: ____________


Operator Production Pharmacist QA Officer

Transfer Of Compressed Tablets to Coating Section:

Total Weight received: _______________ Date: __________________________

Performed by: _____________________ Checked by: ____________________


CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Operator Production Pharmacist
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
QUALITY CONTROL TESTING REPORT AFTER COMPRESSION
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 23 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)

General Tablet Section Compression


Filled By Quality Assurance
Date: Time: Sampled By: Quantity: QA Officer (Sign)

Analysis Report (Filled By QC)


Sample Receiving Date: Sample Receiving Time: Sample Release Date: Sample Release Time: QC Reference No.

Tests Specifications Results


Physical Appearance White Color Round Shape Core Tablet with engraved cut line on one side
Identification:
Average weight/Tablet 210mg/Tablet±7.5%
Diameter 8±0.04mm
Thickness 5±0.04mm
Hardness NMT 10 kg
Friability NMT 1 %
Disintegration Time NMT 15mint
Assay: 90-110% of the label claim of Empagliflozin

LINE CLEARANCE CHECKLIST FOR COATING


PRD OFFICER QA OFFICER

Performed By: ______________ Checked by: ________________ Approved by: ______________


QC Analyst
CONTROLLED Asst. Manager
COPY: NO COPYING WITHOUT MANAGERQC
Q.A PERMISSION QC Manager
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 24 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Yes No Yes No
Sr. # CLEARANCE PARAMETERS
01 Is area properly cleaned and labeled?    
02 Are there any traces of previous Product _______________ Batch #_________ in    
a- Area, Containers, Stools, S.S bowl    
b- Conventional Coating Pan    
START UP OPERATION
03 Are equipment & containers properly cleaned & labeled with Equipment / Product Identification Label?    
04 Are personnel in the blistering room wearing specified clean uniform, gloves and mask?    
05 QC release of the batch to be processed is present?    
06 Is coating machine specific parts (gauges) in calibration status?    
Are Temperature and relative humidity in accordance to the requirements and recorded?
07 Temperature:_______(°C) & Humidity:_________(%)
   
08 Is documentation of previous stages completed?    
All the above parameters are checked and found satisfactory.
PRODUCTION PHARMACIST: _____________ DATE & TIME:_______________ Line Clearance awarded: YES □ NO □
QA OFFICER: _________________ DATE & TIME:________________ REMARKS: _________________________________

LINE clearance for more than one time after rechecking of above parameters each time
Date Time Line clearance status Checked by Rechecked by IPQC

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 25 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

STANDARD COATING PROCEDURE (FILM COATING)

Performed Checked By Verified


Step
COATING PROCEDURE By Production By QA
# Operator Pharmacist Officer
COATING SOLUTION PREPARATION:
1. Sr Ingredients Actual Wt. Sr. Ingredients Actual Wt.
1. 4.
Coat Dry Titanium Dioxide
.
2. IPA 5. PEG 6000
3. Water
Take IPA & add the above mentioned materials in it and mix for 45 minutes.
Mixing started at: ____________ Mixing completed at: _________
Total Mixing Time : _________ Date:__________ Filter the coating solution through appropriate filters.

COATING:
Dedust the core tablets before loading into the pan. Load the core tablet in the Coating pan using SS Bowl. Switch ON the
main power supply & warm the cores for 5 minutes.
Spray the coating solution on tablet bed till all the solution is used. Adjust and maintain the following parameters during
coating.
Coating started at: ____________ Coating completed at: _________
Total Coating Time : _________ Date:__________
After complete coating, transfer the coated tablets from coating pan in the tarred containers equipped with clean polythene
bags. Send request to QA for sampling for physical and chemical analysis & calculate %age weight gain & %age yield.

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 26 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

WEIGHT RECORD OF COATED TABLETS & YIELD CALCULATION


Date: ______________
Checked By
Container Tare Weight Net Weight Performed By Verified By QA
Gross Weight (Kg) Production
Number (Kg) (Kg) Operator Officer
Pharmacist
1
2
3
4
TOTAL NET WEIGHT _________________Kg.
Theoratical Weight:_________ kg Actual weight of coated tablet:____________ Kg

% Yield = _________________ % % Wastage = ________________%

Note: Store the coated tablets in proper Air tight Polythene bags, in labeled containers, in in-process Quarantine Area

Performed by: ____________ Checked by: __________________ Verified by: ____________


Operator Production Pharmacist QA Officer

Transfer Of Coated Tablets to Blistering Section:

Total Weight received: _______________ Date: __________________________


CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Performed by: _____________________
STAMP Checked by: ____________________
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 27 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Operator Packing Pharmacist


QUALITY CONTROL TESTING REPORT AFTER COATING
Filled By Production
Date:
Time: Section: Stage: Section Incharge (Sign)
General Tablet Section Coating
Filled By Quality Assurance
QA Officer
Date: Time: Sampled By: Quantity:
(Sign)

Analysis Report (Filled By QC)


Sample Receiving Sample Receiving Sample Release Sample Release QC Reference
Date: Time: Date: Time: No.

Tests Specifications Results


Physical Appearance White Color Round Shape Coated Tablet with engraved cut line on one side
Identification:
Average weight/Tablet 210mg/Tablet±7.5%
Diameter 8±0.04mm
Thickness 5±0.04mm
Hardness NMT 10 kg
Friability NMT 1 %
Disintegration Time NMT 30mint
Assay: 90-110% of the label claim of Empagliflozin
Remarks: _______________________________________________________________________________

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
PACKING ORDER
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Performed By: ______________
STAMP Checked by: ________________ Approved by: ______________
RED STAMP INDICATES ORIGIONAL DOCUMENT
QC Analyst Asst. Q.C. Manager
RED STAMP INDICATES ORIGIONAL DOCUMENT Q.C.
Page 28 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Date: ______________
Product Name: EMPA 10MG Tablet Batch No: T-005
Mfg. Date: 05-2022 Expiry Date: 04-2024
Batch Size: 420.246gm Batch Quantity: 2000tab
Product Reg. No: ----- Shelf Life: 24months
Section: General Tablet Section Memo: Trail

Actual Checked By Received By


Quantity Qty. Additional Verified
QC. No Packaging Material Return Quantity Wastage Warehouse Packing
Required Issued Qty. By QA Officer
Used Officer Pharmacist
Aluminium foil 01.30 kg 01.30 kg
Alu- Alu Base foil
6.66 kg 6.66 kg
(260mm)
Unit Cartons 200No’s 200No’s
Leaflet 200No’s 200No’s
Shipers 1.00 No’s 1.00 No’s
Transparent tape
1.00 No’s 1.00 No’s

Prepared By: __________ Reviewed By:______________ Verified By: ____________ Approved By: ___________
Section Incharge Production Manager Store Incharge QC Manager

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
PACKING ORDER
Date: ______________ STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
Product Name: EMPA 10MG Tablet Batch No: T-005
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 29 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Mfg. Date: 05-2022 Expiry Date: 04-2024


Batch Size: 420.246gm Batch Quantity: 2000tab
Product Reg. No: ------ Shelf Life: 24Months
Section: General Tablet Section Memo: Trail

Actual Checked By Received By


Quantity Qty. Additional Verified
QC. No Packaging Material Return Quantity Wastage Warehouse Packing
Required Issued Qty. By QA Officer
Used Officer Pharmacist
Aluminium foil 01.30 kg 01.30 kg
Alu- Alu Base foil
6.66 kg 6.66 kg
(260mm)
Unit Cartons 200No’s 200No’s
Leaflet 200No’s 200No’s
Shipers 1.00 No’s 1.00 No’s
Transparent tape
1.00 No’s 1.00 No’s

Prepared By: __________ Reviewed By:______________ Verified By: ____________ Approved By: ___________
Section Incharge Production Manager Store Incharge QC Manager

LINE CLEARANCE CHECKLIST FOR BLISTERING


CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION PRD OFFICER QA OFFICER
Sr. # STAMP CLEARANCE PARAMETERS Yes No Yes No
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
01 Is area properlyRED
cleaned
STAMP and labeled?
STAMP INDICATES ORIGIONAL DOCUMENT
   
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 30 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

02 Are there any traces of previous Product _______________ Batch #________ in    


a- Area, Conveyer Belt, Trays, Containers, Stools, S.S bowl    
b- Automatic Blister Machine    
START UP OPERATION
03 Are equipment & containers properly cleaned & labeled with Equipment / Product Identification Label?    
04 Are personnel in the blistering room wearing specified clean uniform, gloves and mask?    
05 QC release of the batch to be processed is present?    
06 Is blistering machine specific parts (gauges) in calibration status?    
Are Temperature and relative humidity in accordance to the requirements and recorded?
07
Temperature:_______(°C) & Humidity:_________(%)
   
08 Is QC released packaging material to be used for respective batch available?    
09 Correct Embossing of Batch no. & Expiry date on Blisters.    
10 Is documentation of previous stages completed?    
All the above parameters are checked and found satisfactory.
PRODUCTION PHARMACIST: ___________ DATE & TIME:_______________ Line Clearance awarded: YES □ NO □
QA OFFICER : _____________ DATE & TIME:________________ REMARKS: _________________________________

LINE clearance for more than one time after rechecking of above parameters each time
Date Time Line clearance status Checked by Rechecked by IPQC

EMBOSSING INFORMATION
Batch No.& Expiry Date
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
T-005 EXP 04-2024
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
Attach Verified Embossed Empty Blister Specimen Here
RED
Attach First STAMP INDICATES ORIGIONAL DOCUMENT
Blister Attach Second Blister Attach Third Blister
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 31 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Performed By: ____________ Checked By: ___________________ Verified By: ___________


Operator Production Pharmacist QA Officer

IN-PROCESS CONTROL SHEET FOR BLISTERING OF TABLETS

Date: _____________Start Time: ____________Close


CONTROLLED Time: ___________
COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION Status
STAMP YES
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
: ✔ NO : X
Checking Parameters
Date Time STAMP Checked by Remarks
RED STAMP INDICATES ORIGIONAL DOCUMENT
Embossing Blisters Foil Status
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 32 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Bulk inspection of
Batch No. Exp. Date Leakage Test Cutting Text Printing
product

REMARKS: ________________________________________________________________________________
Production Pharmacist________________ QA Officer: ________________
Note: 1) QA officer will use Black ball point while Production officer will use Blue ball point.
2) In process entries are taken every 30 minutes by QA and production alternatively.
TEAM LAY OUT SHEET AT BLISTERING STAGE
Start
CONTROLLED Time:NO COPYING WITHOUT MANAGER Q.A PERMISSION
COPY: Close Time:
STAMP Start Date: Close Date:
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 33 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Name Time In Time Out Total Time

Performed By: ____________ Checked By: ____________________


Operator Production Pharmacist

LINE CLEARANCE CHECKLIST FOR PRINTING


PRD OFFICER QA OFFICER
Sr. # CLEARANCE PARAMETERS Yes No Yes No
01 Is area properly cleaned andlabeled?
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION    
STAMP
02 Are there any traces of previousCOPY:
CONTROLLED NO_______________
Product COPYING WITHOUT MANAGER
Batch Q.A PERMISSION
#________ in    
STAMP
a- RED STAMP INDICATES
Area, Conveyer Belt ORIGIONAL DOCUMENT    
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 34 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

START UP OPERATION
03 Are equipment & containers properly cleaned &labeled withEquipment / Product Identification Label?    
04 Are personnel in the Printing room wearing specified clean uniform and mask?    
05 Is printing machine specific parts (gauges) in calibration status?    
Are Temperature and relative humidity in accordance to the requirements and recorded?
06    
TEMP______HUMIDITY_____
07 Is QC released packaging material to be used for respective batch available?    
08 Is documentation of previous stages completed?    
09 Correct Printing of Batch no. ,Mfg Date &Expiry date .    
_______________________
PRODUCTION OFFICER DATE &TIME:_______________ Line Clearance awarded: YES □ NO □
___________
QA OFFICER DATE &TIME:________________ REMARKS: ________________________________________________

LINE clearance for more than one time after rechecking of above parameters each time
Date Time Line clearance status Checked by Rechecked by IPQC

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 35 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

OVER PRINTING INFORMATION


Date: Time:
Batch No.: Batch Size:
Operator (Name): Signature:

Over printing information on unit carton:


Batch # Mfg. Date Expiry Date MRP Rs.
T-005 05-2022 04-2024 ----

Printing Incharge: ___________Production Pharmacist: ___________QA Officer: ___________

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 36 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

__

CONTROLLED
IN-PROCESS CHECK COPY:PRINTING
SHEET FOR NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Date STAMP Time B. No Mfg. Date Expiry Date M.R.P Rs. Checked by
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 37 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Prod. QA

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 38 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

TEAM LAY OUT SHEET AT OVER PRINTING STAGE


Start Time: Close Time:
Start Date: Close Date:

Date
Operator

Performed By: ____________ Checked By: ____________________


Operator
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION Production Officer
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
LINE CLEARANCE CHECKLIST FOR PACKING
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 39 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

PRD OFFICER QA OFFICER


Sr.# CLEARANCE PARAMETERS Yes No Yes No
01 Is area properly cleaned and labeled?    
Are there any traces of previous Product ____________Batch__________ in Area, Conveyer Belt, Shippers &
02    
Pallets
START UP OPERATION
03 Are equipment cleaned & shippers properly labeled with Equipment / Product Identification Label?    
04 Are personnel in the Packaging area wearing specified clean uniform?    
05 Is documentation of previous stages completed?    
06 Is QC released Packaging material pertaining to respective batch available?    
Are Temperature and relative humidity in accordance to the requirements and recorded?    
07
Temperature:_______(°C) & Humidity:_________(%)
08 Correct Over printing information on unit Carton    
a- Product Name    
b- Pack Size / Strength    
c- Batch No.    
d- Mfg. Date , Expiry Date    
e- MRP / PS Stamp    
09 Correct Embossing/ Over printing information on Blisters available?    
10 Presence of literature?    
11 QC release of the batch to be processed is present?    
All the above parameters are checked and found satisfactory.
PRODUCTION OFFICER:______________ DATE & TIME:_______________ Line Clearance awarded: YES □ NO □
QA OFFICER: _______________ DATE & TIME:________________ REMARKS: _________________________________
LINE clearance for more than one
CONTROLLED time NO
COPY: afterCOPYING
rechecking of above parameters
WITHOUT MANAGEReach time
Q.A PERMISSION
Date Time
STAMP Line clearance status
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Checked by Rechecked by IPQC
STAMP
TEAM LAYOUT SHEET AT PACKING STAGE
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 40 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Packing Start Time: Packing Closing Time:

Packing Starting Date: Packing Completion Date:

Name Time In Time Out Total Time

Checked By: ___________________ Verified by: _____________________


Belt Incharge Production Pharmacist
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP IN-PROCESS CONTROL SHEET FOR PACKING
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
REDTime:
Date: ____________Start STAMP INDICATES ORIGIONAL
______________Close DOCUMENT
Time _____________
Status
RED STAMP INDICATES ORIGIONAL DOCUMENT
YES : ✔ NO : X Page 41 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

Bulk inspection Unit carton information Shippers packing


Presence of Retained
Date Time Mfg. Exp. No of Labeling, Checked by
Blisters Leaflet Unit Cartons Batch No MRP (Rs.) Leaflet Samples
Date Date Packs Sealing

REMARKS: ________________________________________________________________________________

Packing Pharmacist: _____________ Q.A. Officer: _______________

NOTE: 1) In process entries are taken after every 45 minutes by QA and Production alternatively.
2) QA officer will use Black ball point while Production officer will use Blue ball point.

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 42 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

CERTIFICATE OF ANALYSIS
Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
General Tablet Section Finished
Filled By Quality Assurance
Date: Time: Sampled By Quantity QA Officer (Sign)

Analysis Report (Filled By QC)


Sample Receiving Sample Receiving Sample Release Sample Release Time: QC Reference
Date: Time: Date: No.

Tests Specifications Results


White Color Round Shape Coated Tablet with engraved cut line on one side blistered in
Physical Appearance Alu/Alu ,packed in unit carton with leaflet pack size 2*7s.
Identification:
Average weight/Tablet 210mg/Tablet±7.5%
Width 8±0.04mm
Thickness 5±0.04mm
Hardness NMT 10 kg
Friability NMT 1 %
Disintegration Time NMT 30mint
Dissolution NLT 75% as label claim
Assay: 90-110% of the label claim of Empagliflozin

Remarks: _________________________________________________________________________
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
Checked By: ________________ VerifiedORIGIONAL
RED STAMP INDICATES By: _______________
DOCUMENT Approved By: ______________
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 43 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

QC Analyst Q.C. Manager QA Manager

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 44 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

FINISHED GOODS TRANSFER NOTE


For Trail: Pack Size: 2*7’s / unit carton
No of shippers Checked By Received by
Date Mfg. Date Exp. Date Total Quantity R&D
Full Part Box R&D Officer QA Officer Officer

Grand Total
Remarks: __________________________________________________________________________
Verified By: ____________
Section Incharge Production Manager Store Incharge

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 45 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

PACKING MATERIALS RECONCILIATION FOR COMMERCIAL


Date__________
Quantity Quantity Quantity Quantity Received
Description
Issued Used Rejected Returned By
Aluminum Foil
Alu-Alu Base Foil 260mm
Unit Carton
Leaflet
Outer Shipper
Packing Tape

Remarks: __________________________________________________________________________________
Section Incharge Production Manager Store Incharge QA Manager

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 46 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

BATCH RECONCILIATION

Sr. # Quantity Produced (Total Packs)

1 Commercial Packs
2 QA Retained Samples
3 Left Over (If Any With Adjustment)
4 Theoretical Yield
5 Practical Yield
6 Process Wastage
7 Date Of Completion

Remarks:_______________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


STAMP
Checked By: ______________
CONTROLLEDReviewed
COPY: NO By: _________________
COPYING Approved
WITHOUT MANAGER Q.A By: _____________
PERMISSION
SectionRED
Incharge
STAMP Production Manager
STAMP INDICATES ORIGIONAL DOCUMENT
QA Manager
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 47 of 48
BRIELL PHARMACEUTICALS R&D Dept.

Product Code: ------ Doc no: RD/BMR/001


PRODUCT NAME: EMPA 10MG TABLET
Revision no:00
Reg NO: ----- BATCH NO: T-005 Batch Size: 2000tab Mfg.: 05-2022 Exp.: 04-2024 Revision date: 01-02-2022
Prepared By Verfied By Approved By Authorized By
Production Incharge Quality Control Incharge Quality Assurance Incharge Plant manager

DESTRUCTION NOTE

IN PROCESS MATERIAL REJECTION


Sign.
Quantity Reason for
Date Material QA
Destroyed destruction Production Officer
Officer
Printed Foil
Alu-Alu foil
Unit Cartons
Leaflets

Remarks: _________________________________________________________________________

CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION


Checked By: ______________
STAMP Reviewed By: _________________ Approved By: ___________
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Section Incharge
STAMP
Production Manager QA Manager
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 48 of 48

You might also like